Study links AstraZeneca's Covid vaccine to higher risk of very rare clotSeveral countries have already altered their advice after previous research indicated that, in rare number of cases, thrombosis with thromb...
Novavax's protein-based jab offers better immunity against new variants: CEO Stanley ErckNovavax's protein-based vaccine was approved for emergency use by the US Food and Drug Administration (USFDA) last month in India.
SII is working on an Omicron-specific vaccine, may launch it by the end of this year: ReportSII Chief Executive Officer Adar Poonawalla told NDTV that the vaccine is being developed in collaboration with Novavax. Poonawalla further...
Covid-19 mRNA jabs safe during pregnancy: Lancet StudyThe study found 7.3% of pregnant women experienced health events requiring time off work or school or needing medical attention, such as he...
NTAGI could decide on mRNA vaccine's inclusion in national drive next weekIndia's drug regulator approved Gennova's mRNA vaccine for restricted use in emergency situations in adults early this week.
Panel recommends emergency use nod to India's 1st mRNA vaccineThe Subject Expert Committee recommended the authorisation in a meeting held on Friday. The vaccine is developed by Pune-based Gennova Biop...
DCGI approves indigenous mRNA Covid jab for emergency use in 18 yrs & aboveAbout 70 lakh doses of the vaccine have already been cleared by the government’s nodal Central Drug Laboratory (CDL) at Kasauli and it is e...
Gennova closes in on nod for mRNA vax developed in IndiaGennova had in April submitted interim data on India's first indigenously developed mRNA Covid-19 vaccine to the Central Drug Standard Cont...
COVID-19: Government to expedite process of recognition of Biological E Corbevax by other countries"It is necessary to quickly initiate the process of recognition of the Corbevax vaccine and its certificate by other countries while Biolog...
Gennova's mRNA-based vaccine to be delayedGennova had last month submitted interim data on India's first indigenously developed mRNA Covid vaccine to the drug regulator. The Central...
Gennova Biopharmaceuticals developing Omicron specific vaccineGennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platf...
Certificate to be available for those that get Covid jab abroad: Govt officialCurrently, those that have received a single jab or have been completely vaccinated abroad cannot receive such a certificate. However, off ...
India’s wait for Moderna vaccine could get longerThe US vaccine makers, including Pfizer, have been insisting that the Indian government should indemnify them against lawsuits in case of a...
Mixing Covid vaccines can give good protection, says UK studySome countries like Spain and Germany are already using mixed doses.
Germany serves up Covid jabs in the company canteenThe makeshift vaccination centre at chemicals group Evonik's Hanau site, near Frankfurt, is one of several such pilot projects in Germany. ...
Recovered COVID-19 patients may need only one shot of mRNA vaccines, say scientistsAccording to the researchers, including Florian Krammer from the Icahn School of Medicine in the US, a single dose of mRNA vaccine elicits ...
US buys additional 100 million doses of Moderna vaccineThe agreement brings the total number of Moderna doses bought by the US to 200 million, enough to immunize 100 million people with the two-...